California Biotechnology Foundation

Nonprofit profile at a glance

EIN
770720482
IRS 990 coverage
2012–2024
Forms available
Form 990 2024, Form 990-PF 2011
Location
Sacramento, CA, USA
Phone
9162333499
Rating
64
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Science and Technology N.E.C.

Official website

Reported finances

Revenue
$655,214
Expenses
$738,709
Assets
$-35,094
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

3 people listed

Highest reported compensation

  • Patricia Cooper (Treasurer): $207,072 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The primary objectives and purposes of corporation shall be to educate the public concerning biotechnology and healthcare - related fields

What it reported doing in 2024

Explanationhighlight life science industrys efforts on combating covid-19 and other illnesses * cbf continued publishing weekly covid-19 update newsletter in 2022 with emerging news and pertinent information related to life science advancements in testing, treatments, and vaccines. * cbf used social media, the website, and digital advertising to share updates on the emerging mpox public health challenge. Materials included highlights of efforts to prevent mpox from reaching pandemic status. These efforts were highlighted in cbfs monthly newsletter. * developed covid-19 timeline fact sheet on vaccines, tests, treatments for monthly newsletter. Other education * overview of life sciences in California to policymakers at a briefing. * engaged policymakers through regular email updates, newsletter content and social media. * position cbf as the go-to informational resource to learn more about ca life sciences * event tour of wa life sciences with industry representatives collateral: facts sheets, updates, and newsletters * covid-19 timeline of life science medical innovations fact sheet: steps taken to combat the covid-19 pandemic and dispel misinformation related to vaccine development and deployment. * life science innovations fight covid-19 fact sheet: cas role in developing approaches to testing, clinical trials, vaccines, and treatments.* jama study examines whether 340b drug discount program genuinely serves vulnerable communities fact sheet: developed in response to a jama study showing that 340b benefits primarily served white, affluent areas. * dmhc report shows health plan profit andnon-medical expenses far exceed rx expenditures fact sheet: dmhc reports on prescription drug consumer expenditures. Maintain stakeholder relationships * biocom 2021 economic impact report databook information * regularly attendance at a variety of stakeholder meetings* highlight stakeholders at events, and in newsletters and social media * amplify the latest stakeholder news and events execute social media campaign to leverage facts around life sciences in ca * designed and executed multiple social media and digital display campaigns to educate stakeholders. * strategically deployed digital to support priority activities of the team to bring historically offline activities into a digital environment. * cbf maintains a robust organic social media presence including sharing the latest news and events from stakeholder and highlighting healthcare stakeholders on social media during awareness months such as hispanic heritage month and breast cancer awareness month.

Operating model

Revenue model
Membership-supported. 63% of the money available for current operations came from membership dues.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Few specific pay-setting methods are documented in the filing; unanswered boxes are not proof of absence and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 77
  • Transparency & Controls: 65
  • Accountability: 44
  • Sustainability: 8
  • Growth: 80

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 90.2%; rating input score 90
  • Program expense ratio: 80%; rating input score 80
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 0 of 6 controls in place; rating input score 0
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Missing
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 66.7%; rating input score 67; 14th percentile among comparable filings
  • Governance controls: 1 of 8 controls in place; rating input score 12
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: Fail
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Fail
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: -12.7%; rating input score 14; 14th percentile among comparable filings
  • Total-asset coverage ratio: -0.05; rating input score 0; 0th percentile among comparable filings
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: 28%; rating input score 8; 8th percentile among comparable filings

Growth

  • Program expense growth: 4.4% per year; rating input score 100; 39th percentile among comparable filings
  • Revenue growth: 3.3% per year; rating input score 100; 33rd percentile among comparable filings
  • Asset growth: -18.3% per year; rating input score 0; 2nd percentile among comparable filings

Details

  • Where the money goes: 90.2% of revenue deployed · 80% of spending went to programs
  • Governance: 2 of 3 board members independent · 1 of 8 filing controls reported
  • Programs: 1 filed program accomplishment · $591K in reported program spending
  • Leadership: top reported pay $207K · 3 people listed · 0 of 6 pay-setting controls reported
  • Highest-paid contractors: 2 contractors listed · $277K reported
  • Consistency: 21 of 21 current checks pass
  • Schedules: 5 filed schedules · includes major donors and executive pay
  • Filing history: 12 filing years from 2012 to 2024
  • Contacts: How to reach this organization
  • Money network: 6 filed money-flow records
  • Related organizations: Filed and resolved organization relationships.
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Transparency & Controls: Pay-setting controls scored 0/100.
  • High — Accountability: Governance controls: 6 of 7 not reported.
  • High — Sustainability: Operating margin scored 14/100.
  • High — Sustainability: Total-asset coverage ratio scored 0/100.
  • High — Growth: Asset growth scored 0/100.
  • High — Sustainability: Officer compensation ratio scored 8/100.